|
C13ORF34 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.4182000018792E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06560000046052E-07 |
| Normal-vs-Stage2 |
2.360300E-04 |
| Normal-vs-Stage3 |
8.52920001293E-09 |
| Normal-vs-Stage4 |
4.82270001711527E-10 |
| Stage1-vs-Stage2 |
5.155400E-01 |
| Stage1-vs-Stage3 |
2.097700E-02 |
| Stage1-vs-Stage4 |
3.403900E-04 |
| Stage2-vs-Stage3 |
3.569600E-01 |
| Stage2-vs-Stage4 |
3.154500E-02 |
| Stage3-vs-Stage4 |
9.870200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.79739597941875E-11 |
| Normal-vs-AfricanAmerican |
5.155500E-03 |
| Normal-vs-Asian |
5.248400E-02 |
| Caucasian-vs-AfricanAmerican |
2.557000E-03 |
| Caucasian-vs-Asian |
2.275200E-01 |
| AfricanAmerican-vs-Asian |
1.166960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.14270037876452E-10 |
| Normal-vs-Female |
6.88619999911211E-08 |
| Male-vs-Female |
2.444800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.642400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.54529997079089E-09 |
| Normal-vs-Age(61-80Yrs) |
3.88070020562736E-10 |
| Normal-vs-Age(81-100Yrs) |
3.275600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.104800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.140000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.380810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.657000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.467790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.125500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.421720E-02 |
| Normal-vs-Grade 2 |
9.91080000289912E-08 |
| Normal-vs-Grade 3 |
3.02290004139394E-09 |
| Normal-vs-Grade 4 |
1.62500000122634E-08 |
| Grade 1-vs-Grade 2 |
5.869800E-01 |
| Grade 1-vs-Grade 3 |
3.029000E-01 |
| Grade 1-vs-Grade 4 |
9.637700E-03 |
| Grade 2-vs-Grade 3 |
3.782400E-01 |
| Grade 2-vs-Grade 4 |
6.159500E-03 |
| Grade 3-vs-Grade 4 |
2.260200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.3197000048315E-08 |
| Normal-vs-ccB subtype |
3.35160010855873E-10 |
| ccA subtype-vs-ccB subtype |
3.772100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.71929997911025E-09 |
| Normal-vs-N1 |
1.257090E-03 |
| N0-vs-N1 |
4.724100E-02 |
|
|
